Biomea Fusion Inc is a clinical-stage diabetes and obesity medicines company focused on the discovery and development of oral covalent small-molecule drugs to treat patients with metabolic diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
BMEA is expected to report earnings to fall 16.74% to -22 cents per share on April 06
Q4'25
Est.
$-0.22
Q3'25
Beat
by $0.02
Q2'25
Beat
by $0.03
Q1'25
Beat
by $0.12
Q4'24
Beat
by $0.10
The last earnings report on November 04 showed earnings per share of -27 cents, beating the estimate of -28 cents. With 1.17M shares outstanding, the current market capitalization sits at 96.86M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BMEA showed earnings on November 04, 2025. You can read more about the earnings report here.